March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Polyamines Contribute to Diabetic Retinal Edema
Author Affiliations & Notes
  • Bruce A. Berkowitz
    Anatomy/Cell Biol & Ophthal,
    Wayne State Univ Sch of Med, Detroit, Michigan
  • Leo Hawel, III
    University of California, Riverside, Riverside, California
  • Craig Byus
    University of California, Riverside, Riverside, California
  • David P. Bissig
    Anatomy and Cell Biology, Wayne State Univ School of Med, Detroit, Michigan
  • Robin Roberts
    Anatomy & Cell Biol,
    Wayne State Univ Sch of Med, Detroit, Michigan
  • Footnotes
    Commercial Relationships  Bruce A. Berkowitz, None; Leo Hawel, III, None; Craig Byus, None; David P. Bissig, None; Robin Roberts, None
  • Footnotes
    Support  MMPC MICROMouse Program, Juvenile Diabetes Research Foundation
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 5763. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Bruce A. Berkowitz, Leo Hawel, III, Craig Byus, David P. Bissig, Robin Roberts; Polyamines Contribute to Diabetic Retinal Edema. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5763.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : The single most common cause of severe vision loss in patients with diabetes is macular edema. Fundamental questions remain as to how such edema develops and how best to treat it. Patients with diabetes have elevated vitreous polyamine levels but it is uncertain if polyamines (i.e., putrescine, spermidine, spermine) are linked with retinal edema. In this study, we tested the hypothesis that ocular polyamines contribute to experimental diabetic retinal edema.

Methods: : We studied 3 mo diabetic male Sprague Dawley (SD) rats with and without treatment of α-difluoromethylornithine (DFMO,200 mg/kg, 1x/day for a week, sq, a specific and irreversible inhibitor of the first and rate-limiting step in polyamine synthesis) and 2 mo diabetic male C57Bl/6 mice with and without systemic putrescine treatment (10 mg/kg, 2x/day for 1 week, SQ); age- and strain-matched controls were also examined. Outcome metrics included vitreous polyamine content (HPLC), central retinal thickness (MRI), and intraretinal water mobility profiles (diffusion-weighted MRI).

Results: : In diabetic male SD rats, a previously established model of diabetic retinal edema, vitreous spermidine and spermine, but not putrescine, levels were supernormal (P < 0.05). A direct correlation (P < 0.05) was found between polyamine content and central retinal thickness. In contrast, diabetic C57Bl/6 mice had thinner central retina than controls (P < 0.05). Within-retina changes in water mobility in vivo were consistent with the presence of edema in the diabetic rats and dehydration in the diabetic mice. DFMO intervention reduced (P < 0.05) supernormal central retinal thickness in diabetic male SD rats; exogenous putrescine increased (P < 0.05) subnormal central retinal thickness in diabetic mice.

Conclusions: : These data highlight, for the first time, a role for polyamines in experimental diabetic retinal edema.

Keywords: edema • diabetic retinopathy • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.